Predictors of revision endoscopic sinus surgery in Finnish patients with chronic rhinosinusitis with nasal polyps

被引:0
|
作者
Toppila-Salmi, Sanna [1 ,2 ,3 ,4 ]
Lyly, Annina [5 ,6 ]
Simin, Johanna [7 ]
Aakko, Juhani [7 ]
Olsen, Helga Haugom [5 ]
Lehtimaki, Lauri [8 ,9 ]
机构
[1] Univ Eastern Finland, Dept Otorhinolaryngol, Kuopio, Finland
[2] Wellbeing Serv Cty Pohjois Savo, Dept Otorhinolaryngol, Kuopio, Finland
[3] Helsinki Univ Hosp, Inflammat Ctr, Dept Allergol, Helsinki, Finland
[4] Univ Helsinki, Helsinki, Finland
[5] AstraZeneca Nordics, Med Affairs, Espoo, Finland
[6] AstraZeneca Nordics, Med & Regulatory, Oslo, Norway
[7] Medaffcon Oy, Espoo, Finland
[8] Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland
[9] Tampere Univ Hosp, Allergy Ctr, Tampere, Finland
关键词
chronic rhinosinusitis; CRSwNP; endoscopic surgery; nasal polyps; revision surgery; PREVALENCE; GUIDELINES; OUTCOMES; ASTHMA;
D O I
10.1002/clt2.70032
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background Although patients with chronic rhinosinusitis with nasal polyps (CRSwNP) may benefit from endoscopic sinus surgery (ESS), some patients will experience polyp recurrence, adding to the overall disease burden of CRSwNP. We aimed to investigate predictors of revision ESS in patients with CRSwNP. Methods A nationwide population-based study including all adults diagnosed with CRSwNP who had surgical procedure codes for ESS (N = 3506), followed up between January 2012 and December 2019. Logistic regression models provided adjusted odds ratios (OR) with 95% confidence intervals (CIs) for the odds of revision surgery within one and 3 years post-index surgery. Results 559 (15.9%) of the patients had at least one revision surgery during the follow-up. Median time to revision of ESS was 425 days (interquartile range: 213-898). Baseline asthma (OR = 1.58, 95% CI 1.17-2.12) and antibiotic use (OR = 1.61, 95% CI 1.27-2.04) were associated with higher odds of revision ESS, particularly within 3 years post-index surgery, whereas Increasing age was inversely associated with the odds of ESS revision (OR = 0.82, 95% CI 0.76-0.88). The highest odds of revision ESS were observed within 3 years post-index surgery in patients who had undergone extensive surgery at index (OR = 14.13, 95% CI 3.41-95.64) compared with those who had undergone limited surgery. OCS use was frequent among CRSwNP patients, with a higher cumulative dose in patients undergoing multiple ESS revisions (63%, n = 97, median daily dose 3.29 mg, IQR: 1.64-3.70) compared with patients without revisions (49%, n = 1361 and 1.64 mg, IQR: 1.64-3.29, respectively. p-value <0.001). Conclusions A small proportion of CRSwNP patients require revision ESS with associated high cumulative OCS doses, highlighting the need for additional therapies to achieve disease control and reduce the corticosteroid burden. A few simple baseline characteristics can predict the need for recurrent surgery among the patients with CRSwNP.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Long-Term Clinical Outcomes in Patients with Chronic Rhinosinusitis with Nasal Polyps Associated with Expanded Types of Endoscopic Sinus Surgery
    Martin-Jimenez, Daniel
    Moreno-Luna, Ramon
    Callejon-Leblic, Amparo
    del Cuvillo, Alfonso
    Ebert, Charles S.
    Maza-Solano, Juan
    Gonzalez-Garcia, Jaime
    Infante-Cossio, Pedro
    Sanchez-Gomez, Serafin
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (03)
  • [42] Quality of life improvement from sinus surgery in chronic rhinosinusitis patients with asthma and nasal polyps
    Zhang, Zi
    Adappa, Nithin D.
    Doghramji, Laurel J.
    Chiu, Alexander G.
    Lautenbach, Ebbing
    Cohen, Noam A.
    Palmer, James N.
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2014, 4 (11) : 885 - 892
  • [43] Voice outcomes after endoscopic sinus surgery in patients with chronic rhinosinusitis with nasal polyposis
    Hall, Christian A.
    Hernandez, Stephen C.
    Barry, Rachel A.
    Zito, Brittany A.
    McWhorter, Andrew J.
    Fink, Daniel S.
    Barham, Henry P.
    LARYNGOSCOPE, 2019, 129 (02): : 299 - 302
  • [44] Sleep quality improves with endoscopic sinus surgery in patients with chronic rhinosinusitis and nasal polyposis
    Varendh, Maria
    Johannisson, Arne
    Hrubos-Strom, Harald
    Andersson, Morgan
    RHINOLOGY, 2017, 55 (01) : 45 - 52
  • [45] Reserve Biologics for Chronic Rhinosinusitis with Nasal Polyps After Failed Sinus Surgery
    Allen, David Z.
    Luong, Amber U.
    CURRENT OTORHINOLARYNGOLOGY REPORTS, 2023, 11 (03) : 266 - 272
  • [46] Reserve Biologics for Chronic Rhinosinusitis with Nasal Polyps After Failed Sinus Surgery
    David Z. Allen
    Amber U. Luong
    Current Otorhinolaryngology Reports, 2023, 11 : 266 - 272
  • [47] Complications of primary and revision functional endoscopic sinus surgery for chronic rhinosinusitis
    Krings, James G.
    Kallogjeri, Dorina
    Wineland, Andre
    Nepple, Kenneth G.
    Piccirillo, Jay F.
    Getz, Anne E.
    LARYNGOSCOPE, 2014, 124 (04): : 838 - 845
  • [48] Change in eosinophil biomarkers after full-house endoscopic sinus surgery in chronic rhinosinusitis with nasal polyps
    Phetpong, Juthaporn
    Seresirikachorn, Kachorn
    Aeumjaturapat, Songklot
    Chusakul, Supinda
    Kanjanaumporn, Jesada
    Wongpiyabovorn, Jongkonnee
    Snidvongs, Kornkiat
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2022, 12 (10) : 1291 - 1294
  • [49] Functional endoscopic sinus surgery improves the quality of life in children suffering from chronic rhinosinusitis with nasal polyps
    Fetta, Melina
    Tsilis, Nikolaos S.
    Segas, John V.
    Nikolopoulos, Thomas P.
    Vlastarakos, Petros V.
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2017, 100 : 145 - 148
  • [50] Long-term outcomes of different endoscopic sinus surgery in recurrent chronic rhinosinusitis with nasal polyps and asthma
    Zhang, Luo
    Zhang, Yuan
    Gao, Yunbo
    Wang, Kuiji
    Lou, Hongfei
    Meng, Yifan
    Wang, Chengshuo
    RHINOLOGY, 2020, 58 (02) : 126 - 135